CDK6 and triple-negative breast carcinoma: For example, in triple-negative breast cancer (TNBC), IGF2BP2 enhances cell proliferation and facilitates the G1/S phase transition by directly regulating CDK6 in an m6A-dependent manner and recruiting EIF4A1 to promote CDK6 translation output [85].